Cancer development is often associated with the dysregulation of receptor-mediated signaling pathways. Abnormal receptor activity can lead to uncontrolled cell growth and survival, contributing to the formation and progression of tumors. Several types of receptors are implicated in cancer, including tyrosine kinase receptors, G-protein coupled receptors, and nuclear receptors.